about
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunizationImmune responses to plasmid DNA encoding the hepatitis C virus core proteinProtection against establishment of retroviral persistence by vaccination with a live attenuated virus.Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus.DNA vaccination against persistent viral infection.Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells.Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro.Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine.Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challengeRecombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.Local antigen in nonlymphoid tissue promotes resident memory CD8+ T cell formation during viral infection.Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccinesT-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8+ T cells.
P2860
Q24670153-1B72A0DA-442E-4774-8486-B6B03D9EF4C2Q27480300-9101812D-E0BA-4A67-B14A-EBEAAFDCF206Q33646493-24662C32-AEC9-40A1-9396-1B1AFE4EC81EQ33783475-B7E776B3-1E24-4304-A033-BADCB8491C34Q34158340-041D7AC0-4E78-4E28-B02A-5AE1DE2E6074Q35833059-8DFC3874-E3E7-45BD-B75C-1F7575E38427Q35838136-484BA683-8FD7-4FF6-9895-3E7C6F5F38C3Q35848078-C0D53EAF-2A94-433E-9483-994E19FE8F1FQ35875924-C0B018A7-8A3A-4ED7-A44D-53DEDD0098DDQ36246319-0BC3F9EC-0F40-4E80-B709-D423CDFAEDD6Q36366362-CA98FE78-37F2-409C-A8A1-B1ED162F0BFAQ36377398-88E1724A-798C-444F-8D80-926E85AAEC78Q36414246-E3DEF86F-674C-4B6B-9238-8AA647A41A16Q36633979-4BEA6881-1173-45E1-93F5-8CFB64B97724Q36659320-85AEA41C-4B08-47DA-BE08-376123EDB0BCQ36949921-9015EED7-4227-4B9C-B8DA-27A4AAF3B6F2Q37196054-B1EE3C8D-AE08-4A29-9F66-8BFCF7A9A25FQ37333743-2C423538-85C1-4B61-B098-216A5E334460Q37374676-0E9C218D-DCF1-4753-87B7-CD4496BADA01Q39603395-68F1C210-5B95-4ED6-A86F-135AD793687FQ39604745-BFB12757-75DA-46BE-8F95-BFB9D8474C91Q39869845-1B766686-4066-48C4-8D45-D1607B01C080Q39877553-C06D6132-A05D-45A7-8796-F98C9D59A9EEQ39878730-968FEE48-410E-4A17-867D-CFD9784DECDAQ47797856-C244BB71-1830-431C-BC2F-B06FF61C7D7A
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Vaccination to prevent persistent viral infection.
@en
type
label
Vaccination to prevent persistent viral infection.
@en
prefLabel
Vaccination to prevent persistent viral infection.
@en
P2093
P2860
P1433
P1476
Vaccination to prevent persistent viral infection
@en
P2093
J C de la Torre
J L Whitton
M B Oldstone
M Eddleston
P2860
P304
P407
P577
1993-07-01T00:00:00Z